GenesisCare is pleased to announce the successful delivery and installation of the Elekta Unity MR-Linac machine, a new highly targeted and innovative cancer treatment, at its centre at St Vincent’s Hospital, Sydney.
St Vincent’s will be the first hospital in NSW to offer the new treatment option and the second in the entire country.
The state-of-the-art technology will allow radiation oncologists for the first time to visualise the cancerous tissue during treatment, combining MRI diagnostics with highly targeted radiation therapy.
The combination enables crystal clear differentiation of soft tissues during treatment and will allow for adjustment in real time (known as adaptive planning) to account for movement in the tumour or surrounding healthy issue.
Associate Professor Dion Forstner, Radiation Oncologist, GenesisCare St Vincent’s Hospital, Sydney, said, “this new technology heralds a new era for radiation therapy and we are excited to be at the forefront of the evolution of cancer treatment in Australia.”
“The Elekta Unity MR-Linac machine will significantly enhance our adaptive planning capabilities and for the first-time radiation oncologists will be able to visualise cancerous tissue during treatment.”
Ryan Ares, Project manager, GenesisCare, said, “The linac drop is a really important construction milestone in the delivery of this project and I congratulate everyone who has been involved in the project to date.”
Lionel Hadjadjeba, President MR-Linac Solutions, Elekta, said, “Elekta, the global radiotherapy company that has introduced Elekta Unity, shares GenesisCare’s focus on delivering the best cancer care technology to patients.
“Cancer patients – and those who treat them – will have greater access to MR-guided adaptive therapy, the most precise form of radiation treatment.”
“We are thrilled to see the progress at St. Vincent’s Hospital and look forward to the first patients having access to this groundbreaking MR-linac technology in 2020.”
Earlier this year, GenesisCare announced the acquisition of a further nine Elekta Unity machines, which will be rolled out in Australia, Asia Pacific and Europe, over the coming years.
To coincide with the acquisition of the machines, GenesisCare and Elekta announced a strategic partnership to advance the ongoing clinical development of adaptive therapy based on real-world evidence.
The partnership will see GenesisCare and Elekta work together to create standardised data repositories that advance adaptive therapy technologies and create a platform to assess the clinical value of radiotherapy.